Replies to post #409568 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

Hoskuld

The article says bulk plaque remains a plausible but unlikely solution. That is contradictory: that solution is plausible. Regardless, that is not the most salient issue with beta amyloid plaque approach: plaque is downstream and removing it (soluble or insoluble forms) does not result in clinically meaningful impact on AD patients.

Best described by XENA a while back ..."Plaque may be a possible symptom of AD but there is no evidence it is the cause". (I think I got that right).